GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Return on Assets (ROA) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROA(%) | 7.42 | -11.86 | -0.54 | 6.74 | 7.11 |
What is the latest Return on Assets (ROA) ratio of GLENMARK PHARMACEUTICALS ?
| Year | Return on Assets (ROA) |
|---|---|
| Mar2025 | 7.42 |
| Mar2024 | -11.86 |
| Mar2023 | -0.54 |
| Mar2022 | 6.74 |
| Mar2021 | 7.11 |
How is Return on Assets (ROA) of GLENMARK PHARMACEUTICALS Trending?
| Years | Return on Assets (ROA) | % Change | |
|---|---|---|---|
| Mar2025 | 7.42 | Positive | |
| Mar2024 | -11.86 | Negative | |
| Mar2023 | -0.54 | Negative | |
| Mar2022 | 6.74 | -5.20 | |
| Mar2021 | 7.11 | - | |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Assets (ROA) ratio of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹56,324.3 Cr | -0.2% | -2.1% | 32.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.2% |
-2.1% |
32.3% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses